CVS Health Co. (NYSE:CVS) Receives Consensus Rating of “Moderate Buy” from Analysts

CVS Health Co. (NYSE:CVS) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-three analysts that are presently covering the firm, Marketbeat reports. Ten investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $75.05.

CVS has been the topic of a number of research reports. Argus cut their target price on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Leerink Partnrs cut CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. SVB Leerink reissued a “market perform” rating and issued a $60.00 target price (down previously from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. Piper Sandler upped their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. Finally, Robert W. Baird started coverage on CVS Health in a research report on Thursday, May 30th. They set a “neutral” rating and a $61.00 price objective for the company.

Insiders Place Their Bets

In other news, Director Edward J. Ludwig bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was bought at an average price of $53.88 per share, with a total value of $53,880.00. Following the acquisition, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.24% of the stock is owned by company insiders.

Institutional Trading of CVS Health

A number of large investors have recently made changes to their positions in the business. Atticus Wealth Management LLC boosted its holdings in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the period. USA Financial Formulas boosted its stake in shares of CVS Health by 573.2% during the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. purchased a new position in CVS Health in the 4th quarter worth about $32,000. Creekmur Asset Management LLC purchased a new stake in CVS Health in the 4th quarter valued at about $34,000. Finally, Steph & Co. grew its stake in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 288 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

CVS stock opened at $57.52 on Wednesday. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The firm’s 50-day moving average price is $59.34 and its two-hundred day moving average price is $70.02. The stock has a market capitalization of $72.21 billion, a price-to-earnings ratio of 10.11, a PEG ratio of 0.56 and a beta of 0.52. CVS Health has a 12-month low of $52.77 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The business had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.20 earnings per share. As a group, equities analysts predict that CVS Health will post 7.02 earnings per share for the current year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.